Inventor · Tustin, CA, US

Wendy M. Blanda

31Patents
11h-index
37Co-inventors
71Inventor score

Filing activity: Apr 29, 2005 → Feb 19, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8512738B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 58 Active
US8821870B2 Method for treating atrophic age related macular degeneration Human Necessities 38 Active
US8318070B2 Ocular implant made by a double extrusion process Human Necessities 36 Active
US8147865B2 Steroid-containing sustained release intraocular implants and related methods Human Necessities 34 Active
US9050336B2 Botulinum toxin formulation Chemistry; Metallurgy 23 Active
US9044477B2 Botulinum toxin formulation Chemistry; Metallurgy 19 Active
US8034370B2 Ocular implant made by a double extrusion process Human Necessities 19 Active
US8034366B2 Ocular implant made by a double extrusion process Human Necessities 17 Active
US8048445B2 Ocular implant made by a double extrusion process Human Necessities 13 Active
US8969415B2 Intraocular drug delivery systems Human Necessities 13 Active
US9161970B2 Dermal filler Emerging Cross-Sectional Technologies 11 Active
US8257730B2 Steroid-containing sustained release intraocular implants and related methods Human Necessities 7 Active
US8771722B2 Methods of treating ocular disease using steroid-containing sustained release intraocular implants Human Necessities 5 Active
US9192511B2 Ocular implant made by a double extrusion process Human Necessities 5 Active
US9622957B2 Dermal filler Emerging Cross-Sectional Technologies 5 Active
US8506987B2 Ocular implant made by a double extrusion process Human Necessities 5 Active
US9327059B2 Steroid-containing sustained release intraocular implants and related methods Human Necessities 5 Active
US7749530B2 Kinase inhibitors Chemistry; Metallurgy 4 Active
US10076526B2 Ocular implant made by a double extrusion process Human Necessities 3 Active
US9233070B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 3 Active
US10363214B2 Method for treating atrophic age related macular degeneration Human Necessities 2 Active
US8785394B2 Sustained action formulation of cyclosporin form 2 Chemistry; Metallurgy 2 Active
US10076492B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 2 Active
US10702539B2 Ocular implant made by a double extrusion process Human Necessities 1 Active
US9919028B2 Autoclavable suspensions of cyclosporin A Form 2 Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.